Our Services

Pharma Medica offers our clients a full service approach. Through our in-house team of scientific expertise we are able to provide a complete spectrum of services from A to Z, helping to simplify your outsourcing needs.

Workflow Scientific Affairs Clinical Affairs Bioanalysis Bioanalysis Scientific Affairs
Certified Supplier of The Canadian Aboriginal and Minority Supplier Council

Why Choose PMRI

When it comes to CROs – you have many options. What makes Pharma Medica the right choice for you? Our unique perspective on contract research has made us “easy” to work with and helps us to deliver uncompromising quality. This position has been attained through our consistent adherence to our core philosophies.

  • Expertise

    Global expertise in BA/BE studies – we run more than 200 studies per year for TPD, FDA, EMA, MENA, and Australian markets. With over 15 years of in-house data, our biopharmaceutics team has the skills and knowledge that you are looking for.

  • Efficiency

    Our industry leading turnaround time helps you bring your drugs to market faster – we deliver final reports within 10 weeks of study initiation.

  • Quality

    Professionally trained staff, well established ICH-GCP and GLP procedures, successful FDA, EMEA, and ANVISA audits, GLP certification – what else can we say!

  • Capabilities

    With scientific affairs, clinical, and bioanalytical services available to you, we are able to simplify your outsourcing process.

  • Scientific Excellence

    PMRI is distinct within the CRO industry in that we do not have a sales or business development team. We invest these resources into hiring better scientists and clinicians. The core of our management strategy is to grow through experience, expertise, and efficiency – allowing our consistent quality and performance to sell our services for us!

  • Trust

    Our reputation within the pharmaceutical industry for quality, responsiveness, and timeliness is demonstrated by ongoing long-term relationships with the world’s leading drug companies.

For more information contact: